M'sia Sent Techincal Experts To Recent IAEA NDT Expert Mission In Myanmar
Nuclear Malaysia said that its involvement in the mission made Malaysia an active contributor to the safety of the global nuclear technology based infrastructure and left a significant positive impact on the country in terms of recognition of technical expertise and exposure, and strengthens its role as IAEA's strategic partner.
The mission was also part of the international commitment towards the post-disaster safety of infrastructure following the earthquake that hit Myanmar on March 28.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
5 hours ago
- The Sun
Rafflesia name change symbolic but risks global scientific confusion
KOTA BHARU: The proposal to rename Rafflesia with a local term represents a symbolic effort to decolonise the national consciousness and reclaim Malaysia's identity. Universiti Malaysia Kelantan Faculty of Earth Sciences Dean Associate Prof Dr Zulhazman Hamzah stated this idea requires careful consideration despite its symbolic importance. He said the idea reflects an aspiration to elevate local heritage that predates Western colonisation, while recognising the indigenous communities who have long known the flower. 'Symbolically, it is a declaration that Malaysia owns its heritage entirely, free from colonial legacy.' The scholar noted that the naming of Rafflesia dates back to 1818 when it was discovered in Bengkulu, Sumatra, by Sir Stamford Raffles and Dr Joseph Arnold. Zulhazman added that adopting a local name, such as bunga pakma or terms rooted in ethnic traditions, would serve as recognition of existing traditional knowledge. The Rafflesia, known by various local names, reflects the country's cultural diversity. The Kelantanese call it bunga Pokma, the Temiar in Lojing refer to it as bunga Malang, the Kadazan-Dusun as bunga Patma, and the southern Thai Malays as bunga Kekmo. Whereas in Thailand, it is known as Bua Put. Zulhazman said recognising these local names would not only preserve linguistic heritage but also serve as an educational tool to understand pre-colonial history. However, he cautioned that replacing Rafflesia with a local name poses significant challenges, particularly scientific and global confusion. The term has been used in international scientific literature for more than 200 years to refer to a genus comprising over 40 species across Southeast Asia. 'If the official name is changed at the national level, it could create inconsistencies with the standard species nomenclature recognised by the global scientific community.' He added that issues of cost and practicality must also be considered, as changes would affect textbooks, signage, tourism materials and official government websites. Malaysia's multiethnic makeup could also complicate matters, as selecting only one local name might spark dissatisfaction among other communities. As a middle ground, Zulhazman proposed a dual-name approach, for example, Rafflesia (Bunga Pakma), in official, tourism and educational contexts. This, he said, would balance scientific integrity with cultural recognition. 'What matters more is prioritising research, education and conservation of this unique flower so that Malaysia can emerge as a global leader in its protection, regardless of the name used.' Machang MP Wan Ahmad Fayhsal Wan Ahmad Kamal recently proposed renaming the Rafflesia in conjunction with the 68th National Day. – Bernama
Sinar Daily
11 hours ago
- Sinar Daily
Chinese medical team claims insulin-free breakthrough in type 1 diabetes treatment
This breakthrough offers new hope for global T1DM treatment and marks a remarkable advance in integrated Chinese and Western medicine for autoimmune diseases. 21 Aug 2025 04:08pm This approach combined traditional Chinese and Western medicine, thereby achieving a functional cure, recording the longest duration of insulin discontinuation, reaching 14 months. Photo illustrated by Sinar Daily. Photo by Bernama KUALA LUMPUR - Shenzhen Hengsheng Hospital in China has announced a major breakthrough in the treatment of Type 1 diabetes mellitus (T1DM), revealing that 24 patients have successfully discontinued insulin therapy using a holistic integrative medicine (HIM) approach. Led by Professor An Chiying and her medical team, this approach combined traditional Chinese and Western medicine, thereby achieving a functional cure, recording the longest duration of insulin discontinuation, reaching 14 months. The hospital in a statement said this breakthrough offers new hope for global T1DM treatment and marks a remarkable advance in integrated Chinese and Western medicine for autoimmune diseases. Professor An said functional cure enables partial restoration of islet function sufficient to meet daily metabolic needs. She noted that early-diagnosed patients with residual islet function with C-peptide over 0.5 nanogrammes per millilitre (ng/ml) are the most likely to benefit. Meanwhile, Academician Fan Daiming of the Chinese Academy of Engineering called the findings a bold challenge to the long-standing belief that T1DM patients must rely on insulin for life. He praised the HIM model as a promising new paradigm in autoimmune disease care. Over a two-year clinical observation period, the team has applied the HIM model, blending traditional Chinese medicine (TCM), orthomolecular medicine, functional medicine, and lifestyle medicine, as well as precision digital health monitoring, to 70 T1DM patients. Of those, 24 patients (34 per cent) achieved a functional cure, maintaining stable blood glucose levels without reliance on exogenous insulin. The protocol uses precision diagnostics, artificial intelligence-driven monitoring, immune regulation, and metabolic repair strategies. Patients typically undergo a short three- to five-day hospital stay before continuing outpatient follow-up and dietary management. Globally, there are approximately nine million affected by T1DM and rising healthcare costs. The widespread adoption of HIM health management programmes could significantly reduce the financial and health burdens on patients. - BERNAMA More Like This
Barnama
12 hours ago
- Barnama
Chinese Medical Team Claims Insulin-free Breakthrough In Type 1 Diabetes Treatment
KUALA LUMPUR, Aug 21 (Bernama) -- Shenzhen Hengsheng Hospital in China has announced a major breakthrough in the treatment of Type 1 diabetes mellitus (T1DM), revealing that 24 patients have successfully discontinued insulin therapy using a holistic integrative medicine (HIM) approach. Led by Professor An Chiying and her medical team, this approach combined traditional Chinese and Western medicine, thereby achieving a functional cure, recording the longest duration of insulin discontinuation, reaching 14 months. The hospital in a statement said this breakthrough offers new hope for global T1DM treatment and marks a remarkable advance in integrated Chinese and Western medicine for autoimmune diseases. Professor An said functional cure enables partial restoration of islet function sufficient to meet daily metabolic needs. She noted that early-diagnosed patients with residual islet function with C-peptide over 0.5 nanogrammes per millilitre (ng/ml) are the most likely to benefit. Meanwhile, Academician Fan Daiming of the Chinese Academy of Engineering called the findings a bold challenge to the long-standing belief that T1DM patients must rely on insulin for life. He praised the HIM model as a promising new paradigm in autoimmune disease care. Over a two-year clinical observation period, the team has applied the HIM model, blending traditional Chinese medicine (TCM), orthomolecular medicine, functional medicine, and lifestyle medicine, as well as precision digital health monitoring, to 70 T1DM patients. Of those, 24 patients (34 per cent) achieved a functional cure, maintaining stable blood glucose levels without reliance on exogenous insulin. The protocol uses precision diagnostics, artificial intelligence-driven monitoring, immune regulation, and metabolic repair strategies. Patients typically undergo a short three- to five-day hospital stay before continuing outpatient follow-up and dietary management. Globally, there are approximately nine million affected by T1DM and rising healthcare costs. The widespread adoption of HIM health management programmes could significantly reduce the financial and health burdens on patients.
